This equals the KLK14 elevation in breast cancer tissues we observed in 40 and 61% of cases on RNA and protein level, respectively, and thus may account for the KLK14 elevation in the serum of a proportion of breast cancer patients. The gene discussed is KLK14; the disease is breast cancer.